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The human cytomegalovirus UL37 exon 1 gene encodes the immediate early protein pUL37x1 that has antiapoptotic and
regulatory activities. Deletion mutagenesis analysis of the open reading frame of UL37x1 identified two domains that are
necessary and sufficient for its antiapoptotic activity. These domains are confined within the segments between amino acids
5 to 34, and 118 to 147, respectively. The first domain provides the targeting of the protein to mitochondria. Direct PCR
sequencing of UL37 exon 1 amplified from 26 primary strains of human cytomegalovirus demonstrated that the promoter,
polyadenylation signal, and the two segments of pUL37x1 required for its antiapoptotic function were invariant in all
sequenced strains and identical to those in AD169 pUL37x1. In total, UL37 exon 1 varies between 0.0 and 1.6% at the
nucleotide level from strain AD169. Only 11 amino acids were found to vary in one or more viral strains, and these variations
occurred only in the domains of pUL37x1 dispensable for its antiapoptotic function. We infer from this remarkable
conservation of pUL37x1 in primary strains that this protein and, probably, its antiapoptotic function are required for
productive replication of human cytomegalovirus in humans. © 2001 Academic PressINTRODUCTION
Human cytomegalovirus (HCMV) is a medically sig-
nificant pathogen that causes congenital infections as
well as seriously debilitating or life-threatening infec-
tions in immunocompromised patients (Britt and Alford,
1996). The HCMV UL36-38 immediate early (IE) locus
appears to be essential for HCMV origin-dependent DNA
replication and HCMV growth in cultured human fibro-
blasts (Pari and Anders, 1993; Pari et al., 1993, 1995;
mith and Pari, 1995; Iskenderian et al., 1996; Sarisky
nd Hayward, 1996). The UL36-38 locus encodes several
E products, including the UL37 exon 1 (UL37x1) protein,
wo UL37 N-glycoproteins (gpUL37 and gpUL37M), UL36
protein (pUL36), as well as the early UL38 protein (Wilkin-
son et al., 1984; Kouzarides et al., 1988; Chee et al., 1990;
Al-Barazi and Colberg-Poley, 1996; Colberg-Poley, 1996;
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233Zhang et al., 1996; Goldmacher et al., 1999; Patterson and
Shenk, 1999). It was previously established that UL37
exon 2 and UL37 exon 3 (UL37x3) (Borst et al., 1999;
Goldmacher et al., 1999), as well as UL36 (Patterson and
Shenk, 1999) are not required for HCMV growth in human
fibroblasts in culture. Thus, one of the two remaining
products, either pUL37x1 or pUL38, may account for the
finding that UL36-38 products are required for HCMV
ori-dependent DNA replication and growth in fibroblasts.
pUL37x1 traffics to mitochondria and inhibits apoptosis
induced by a variety of stimuli by blocking cytochrome c
release (Goldmacher et al., 1999). Many viruses encode cell
death suppressors, and suppression of apoptosis is be-
lieved to be critical for viral replication (Tschopp et al., 1998;
O’Brien, 1998). In particular, a number of herpesviruses
encode at least one or more proteins with antiapoptotic
activity such as FLIP and Bcl-2 homologs (Tschopp et al.,
1998), indicating that apoptosis plays an essential role in
restricting propagation of at least some herpesviruses.
Based on these data, it was proposed that the antiapoptotic
function of pUL37x1 may be essential for HCMV replication
(Goldmacher et al., 1999).
pUL37x1 shares no amino acid (aa) sequence homol-
ogy with any known cellular or viral cell death suppres-
sors and is not conserved in any other sequenced hu-
man herpesvirus (Baer et al., 1984; Davison and Scott,
1986; Kouzarides et al., 1988; McGeoch et al., 1988;
0042-6822/01 $35.00
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Conversely, the 230-kb HCMV genome does not seem to
encode any proteins homologous to the other herpesvi-
rus FLIP or Bcl-2 family members.
In addition to its mitochondrial localization, pUL37x1
was also previously found to traffic through the endo-
plasmic reticulum and the Golgi apparatus (Colberg-
Poley et al., 2000), although the functional consequences
of this remain unclear. Also, pUL37x1 was previously
found to increase expression of selected cellular and
viral promoter constructions (Colberg-Poley et al., 1992,
1998; Zhang et al., 1996) and to repress the transcrip-
tional regulation of the HCMV US3 IE promoter by IE1
and IE2 (Biegalke, 1999). These activities may derive, at
least in part, from the antiapoptotic activity of pUL37x1
(Goldmacher et al., 1999), consistent with its apparent
ack of nuclear localization (Colberg-Poley et al., 2000),
which argues against its being a transcription factor.
Alternatively, the regulatory activities of pUL37x1 may
involve signaling from the secretory apparatus or mito-
chondria by a yet undefined mechanism.
If the antiapoptotic function of pUL37x1 is indeed es-
sential for HCMV replication, then there should be se-
FIG. 1. Antiapoptotic activity and intracellular localization of pUL37x1
plasmids, and then 24 h later exposed for an additional 24 h to anti-Fas
microscope. About 15 to 30% HeLa cells transfected with UL37x1myc/pc
activity similar to that of the full-length protein (15 to 30% survival). D3
f 10 to 30% transfected cells correlated with the transfection efficiency
to 40%. In contrast, virtually all cells in control HeLa cultures (nontrans
cells survived). Similarly, some deletion mutants did not have any detec
stably expressed in transfected cells as detected by Western blot an
full-length and deletion mutants were detected with 9E10 anti-myc m
markers for endoplasmic reticulum (see Materials and Methods). In
pUL37x1myc, and the deletion mutants were colocalized with endopla
the result was inconclusive.lective pressure to conserve its structure, in particular
those parts of the molecule that are essential for itsantiapoptotic function. In these experiments, we identi-
fied by deletion mutagenesis the segments of the amino
acid sequence of pUL37x1 that are essential for its
antiapoptotic activity, and examined by direct DNA se-
quencing the degree of conservation of its regulatory
and coding region in multiple primary clinical strains of
HCMV.
RESULTS
Two domains within pUL37x1 are required for its
antiapoptotic activity
To identify functional domains within pUL37x1, we gen-
erated a series of its deletion mutants that span the
entire UL37x1 ORF (AD169 strain). pUL37x1 mutants
were expressed as C-terminally myc-tagged proteins
(Goldmacher et al., 1999). We then examined both the
intracellular localization and the antiapoptotic activity of
these deletion mutants in transient transfection assays
in HeLa cells as described previously (Goldmacher et al.,
1999). The results of these experiments are shown in Fig.
1. The deletion of aa 2–23 or aa 23–34 resulted in a
n mutants. HeLa cells were transiently transfected with the expression
y 1 cycloheximide. The cells were then visually observed under phase
survived this treatment. Some of the deletion mutants had antiapoptotic
L37x1 mutant protected about 10–15% cells in the tests. The survival
a cells as detected with a transiently transfected vector for lacZ of 20
or transfected with empty vector) underwent apoptosis (less than 0.1%
ntiapoptotic activity. All these deletion mutant proteins appeared to be
nofluorescence analysis (see Materials and Methods). pUL37x1myc
nal antibody and counterstained with mitochondrial markers or with
to mitochondrial localization, a significant fraction of the full-length
ticulum, with the possible exception of the D2–23 pUL37x1, for whichdeletio
antibod
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235HCMV pUL37x1 CONSERVATION IN PRIMARY STRAINSabolish its antiapoptotic function. This result indicated
that the aa 5–34 segment contains a domain required for
the antiapoptotic activity of pUL37x1. Similarly, the results
obtained with mutants D115–117 (fully functional), D115–
130 (inactive), D131–147 (inactive), and D148–163 (fully
unctional) indicated that the aa 118–147 segment con-
ains a second domain required for the antiapoptotic
ctivity of pUL37x1. None of the deletions between aa 35
nd aa 117 abolished the antiapoptotic activity of
UL37x1, indicating that the entire aa 35–117 region is
ispensable for its antiapoptotic function. Remarkably, a
iniprotein pUL37x1D35–112/D148–163, consisting es-
sentially of just the two functional domains, retained
antiapoptotic function. Taken together, the properties of
the deletion mutants indicate that two segments of the
amino acid sequence of pUL37x1, aa 5–34 and aa 118–
147, contain two domains necessary and sufficient for its
antiapoptotic function. Immunofluorescence analysis re-
vealed that the mutant lacking aa 2–23 did not colocalize
with mitochondrial markers (Goldmacher et al., 1999),
and that the mutant lacking aa 23–34 colocalized mar-
ginally at best, if at all, with mitochondrial markers. On
the other hand, the mutant D312163, lacking all but the
irst 30 amino acids, did colocalize with the mitochon-
rial markers. This result indicated that the mitochondrial
ocalization signal is located within the aa 2–30 segment.
CMV UL37x1 gene sequences
We examined the conservation of UL37x1 sequences
n primary HCMV strains. For these experiments, we
CR-amplified and sequenced the UL37 promoter and
he polyadenylation signal used for the processing of the
L37x1/38 unspliced RNA in 20 and 8 primary strains,
espectively. Both the UL37 promoter and the UL37x1
olyadenylation signal were invariant in all of the primary
trains examined. We also sequenced the UL37x1 open
T
Amino Acid Variatio
Amino acid
number Nucleotide variations
Amino ac
variation
36 nt 52600 (C3 T) P3 L
68 nt 52504 (C3 G) T3 S
103 Deletion (D) of nt 52398–52400 D of E
115 nt 52363 (A3 G) N3 S
117 nt 52356 (C3 G) I3M
148 nt 52264 (A3 G) Q3 R
149 nt 52261 (G3 A) R3 Q
151 nt 52255 (G3 A) R3 Q
152 nt 52253 (A3 C) M3 L
160 nt 52228 (A3 G) Q3 R
161 nt 52225 (C3 T) S3 F
Note. Pho, hydrophobic; Phi, hydrophilic; 1, positive charge; 2, negeading frame (ORF) from primary HCMV DNA in 26
rimary specimens.
p
cThe UL37x1 ORF is intact in all sequenced HCMV
trains (Table 1 and Fig. 2). Although 23 genetic varia-
ions were found within the HCMV UL37x1 ORF of pri-
ary strains, none resulted in termination codons or
rame shifts of the UL37x1 ORF. Twenty-two of these
ariations are single-nucleotide substitutions and one is
n in-frame deletion of a single codon (nucleotides [nts]
2,398–52,400) (Table 1). Eleven substitutions in HCMV
rimary strains resulted in no amino acid variations (H52,
60, S71, L74, E85, E106, T111, A126, E131, A132, and
139). The UL37x1 ORF sequence of HCMV strain AD169
as found to be identical to the published AD169 se-
uence (Fig. 2) (Kouzarides et al., 1988; Chee et al., 1990).
Only 11 of the 163 amino acids in the UL37x1 ORF were
found to vary in one or more primary strains (Table 1 and
Fig. 2). Importantly, none of these substitutions is within
the two segments that are required for the antiapoptotic
activity of pUL37x1.
DISCUSSION
HCMV laboratory strain AD169 has been cultured
since 1956, and its genome lacks at least 19 genes
known to be present in clinical strains (Cha et al., 1996).
It is therefore all the more remarkable that genetic drift of
UL37x1 sequences has not been observed either in
HCMV passaged long term in the laboratory (strain
AD169) or in the primary strains studied herein. These
findings suggest that the UL37x1 sequences are under
selective pressure to remain invariant during HCMV
growth.
The HCMV UL37 gene encodes three IE proteins that
have regulatory and antiapoptotic activities: pUL37x1,
gpUL37, and gpUL37M (Wilkinson et al., 1984; Kouzarides
et al., 1988; Chee et al., 1990; Al-Barazi and Colberg-
Poley, 1996; Colberg-Poley, 1996; Zhang et al., 1996;
oldmacher et al., 1999). The amino-termini of all UL37
in HCMV pUL37x1
Frequency of
variation Characteristics of substitutions
3/26 Pho (0)3 Pho (0)
1/26 Phi (0)3 Phi (0)
4/26 D of hydrophilic negatively charged residue
2/26 Phi (0)3 Phi (0)
2/26 Pho (0)3 Pho (0)
17/26 Phi (0)3 Phi (1)
1/26 Phi (1)3 Phi (0)
4/26 Phi (1)3 Phi (0)
18/26 Pho (0)3 Pho (0)
1/26 Phi (0)3 Phi (1)
5/26 Phi (0)3 Pho (0)
harge; 0, neutral charge.ABLE 1
ns with
id
sroteins are encoded by UL37x1 sequences and share in
ommon 162 amino acids. The UL37x1 protein has one
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237HCMV pUL37x1 CONSERVATION IN PRIMARY STRAINSadditional unique carboxyl-terminal residue. Down-
stream UL37 exons 2 and 3 sequences encode the
unique sequences of gpUL37 or gpUL37M, that contain
multiple N-glycosylation, a transmembrane sequence,
and a cytosolic tail region (Kouzarides et al., 1988; Al-
Barazi and Colberg-Poley, 1996; Goldmacher et al., 1999).
t was previously established that UL37 exons 2 and 3
re not required for HCMV growth in human fibroblasts
n culture (Borst et al., 1999; Goldmacher et al., 1999).
aken together, these data suggest that the gene product
UL37x1 is essential for HCMV infection.
By using the heteroduplex mobility assay (HMA), we
etermined that variation of UL37x1 sequences in 12
ndependent primary HCMV strains was not detected.
owever, there was detectable variation in HCMV
L37x3 sequences (nts 49,938–50,786) in primary strains
sing HMA. This variation was subsequently mapped to
small region within UL37x3 (nts 50,531–50,840) that
ncodes the amino-proximal six N-glycosylation sites
Contopoulos-Ioannidis and Colberg-Poley, unpublished
esults).
We observed 0.0 to 1.6% variation in 489 nucleotides of
he UL37x1 ORF. However, substitutions at nt 52,314
A 3 G), nt 52,290 (A 3 G), nt 52,264 (A 3 G), and nt
52,253 (A3 C) appeared in more than 65% of the HCMV
rimary strains. Primary strains 24, 25, 26, 31, and 66,
hich contain all of these but no other substitutions, are
t the root of the phylogenetic tree. These primary se-
uences are therefore considered to be consensus for
he HCMV UL37x1 sequences. This is in contrast with
he recent finding of sequence hypervariability within the
L144 ORF in HCMV clinical isolates (Lurain et al., 1999).
An overview of the changes in the UL37x1 ORF in
primary strains is shown in Fig. 3. Only 11 amino acids of
the UL37x1 163 residues vary in one or more of the 26
primary strains sequenced. Five of the 11 variations
substitute similarly charged and functionally equivalent
amino acids to those in pUL37x1 encoded by AD169.
One variation is an in-frame deletion of an acidic residue
within the acidic region. Four of the remaining five vari-
FIG. 3. HCMV UL37x1 ORF substitutions in primary strains. The cons
aa 118–147 containing the two domains necessary and sufficient for
protein (regions dispensable for antiapoptosis) is shown as a thin line.
showing the number of strains out of 26 total in which these sequence
the AD169 strain are also shown.ations mapped to the carboxyl-terminus of pUL37x1. The
last substitution at the carboxyl-terminus replaces thehydrophilic serine with the bulky hydrophobic aromatic
phenylalanine. Most of these substitutions occur infre-
quently in primary strains in only one to five of 26 primary
strains. Nevertheless, two substitutions (Q148R and
M152L) occur frequently (17/26 and 18/26, respectively).
Because these substitutions occur in more than 65% of
the HCMV primary strains, we consider these sequences
rather than sequences in the laboratory strain AD169 to
be consensus sequences.
Deletion mutagenesis analysis of the UL37x1 coding
region revealed two domains required for its antiapop-
totic function, a mitochondria-targeting domain located
within aa 5–34, and a second domain of a yet unidenti-
fied function located within aa 118–147. The rest of the
molecule is dispensable for antiapoptotic activity and
mitochondrial targeting.
Most of the HCMV UL37x1 ORF is identical in all the
strains sequenced. Importantly, the segments covering
the two domains that are necessary and sufficient for the
antiapoptotic activity of the protein were invariant in all
the clinical primary strains. We infer from these data that
antiapoptotic function of pUL37x1 is important for human
cytomegalovirus productive infection in humans. None-
theless, it is possible that other pUL37x1 functions,
which overlap with these domains and are necessary for
HCMV growth in humans might be responsible for the
notable conservation of these sequences.
One could argue that the low variance of HCMV
UL37x1 sequences might result from the requirement for
DNA elements in overlapping sequences. The HCMV
UL38 early promoter (nts 52,174–52,179) is located about
40 nucleotides downstream of UL37x1 sequences (Ten-
ney and Colberg-Poley, 1991a,b). If upstream UL38 pro-
moter elements are located within UL37x1 sequences
and required for UL38 gene transcription at early times of
infection, they predictably would be conserved. However,
the substitutions observed in HCMV primary strains are
inconsistent with an exclusive requirement for DNA ele-
ments. For example, most of the substitutions observed
in pUL37x1 ORF (Q148R, M152L) are in sequences im-
see text) sequence of the pUL37x1 protein with segments aa 5–34 and
poptotic function is shown as filled rectangles, while the rest of the
acid variations in primary clinical strains are shown with parentheses,
resent. The two variations from the primary consensus sequences inensus (
its antia
Aminomediately upstream of the UL38 promoter. When substi-
tutions occur, which alter the charge of the basic domain
C
a
r
c
1
e
238 HAYAJNEH ET AL.(R149Q, R151Q), they are invariably accompanied by a
secondary substitution that presumably compensates for
the first by the addition of an additional positively
charged residue (Q148R) at the carboxyl-terminus of
pUL37x1. These findings argue against an exclusive role
for DNA elements.
Our results suggest that UL37x1 sequences provide de-
sirable primers for PCR amplification of HCMV nucleic
acids in clinical specimens. At the nucleotide level, UL37x1
sequences vary between 0.0 and 1.6% from HCMV (strain
AD169) and between 0.0 and 1.2% from root consensus
sequences of primary strains. Primers used for these stud-
ies were used for PCR amplification of HCMV UL37x1 DNA
in an additional 67 urine specimens (Zorin, Colberg-Poley,
and Holland, unpublished results). IE1 and DNA polymer-
ase DNA sequences were also previously used for PCR
detection of HCMV DNA in clinical specimens. While the
IE1 gene is unique among human herpesviruses, exon 4
sequences are known to vary about 13–18% in clinical
HCMV strains, decreasing the sensitivity of some primers
about 100-fold (Chou, 1992; Zweygberg Wirgart et al., 1998).
onversely, the HCMV DNA polymerase gene shows 7.2
nd 0% variation over a span of 250 nucleotides and 83 aa,
espectively (Zweygberg Wirgart et al., 1998), but is well
onserved among the human herpesviruses (Baer et al.,
984; Davison and Scott, 1986; McGeoch et al., 1988; Chee
t al., 1990; Gompels et al., 1995; Nicholas, 1996; Rawlinson
et al., 1996; Russo et al., 1996). Therefore, HCMV DNA
polymerase PCR primers should be HCMV-specific and
preferably contain new reference sequences (Zweygberg
Wirgart et al., 1998). The uniqueness of HCMV UL37x1
sequences among the human herpesviruses and their ex-
traordinary conservation in multiple clinical strains would
make them eminently suitable for sensitive and specific
PCR detection of HCMV DNA in clinical specimens.
MATERIALS AND METHODS
HCMV primary strains
TABLE 2
HCMV Primers Used for PCR and DNA Sequencing
Primer number Nucleotide numbera
132 52,774–52,797
140 52,236–52,259
154 50,765–50,786
156 52,519–52,498
157 52,498–52,519
172 52,147–52,168
187 51,093–51,115
a The nucleotide numbers are from the HCMV strain AD169 se-
quence in the EMBL Data Bank (accession no. X17403).The specimens used for sequencing included a lung
biopsy (Specimen 1), urine (Specimens 6, 11, 12, 24, 25,26, 28, 29, 32, 52, 53, 54, 70, and 71), urine culture
(Specimens 30, 31, and 33), a gastric biopsy culture
(Specimen 60), purified buffy coat preparation from pe-
ripheral blood (Specimens 62, 64, and 72), and superna-
tants from shell vial assays performed on urine (Speci-
mens 61, 65, 66, 67 and 68). Specimen 33 is the cultured
virus from Specimen 25. The specimens had scored
HCMV-positive by shell vial assay or culture. All strains
from the same patient were considered to be related and
therefore not independent. HCMV DNA was purified from
HFF cells infected with HCMV (strain AD169), originally
obtained from American Type Culture Collection (ATCC,
Rockville, MD), as previously described (Lesperance et
al., 1998), and served as a positive control for all PCR
reactions.
NPCR
The primers used for PCR and NPCR amplifications
(Primer 132 1 Primer 172 and Primer 187 1 Primer 154)
are listed in Table 2. To verify the uniqueness of the
primers for HCMV DNA, the combined (GenBank, EMBL,
DDBJ, and PDB) sequence databases were searched
using the BLASTN Program (Altschul et al., 1990). The
specificity of the designed primer sets was previously
verified by PCR amplification of HCMV-negative clinical
specimens (Lesperance et al., 1998; Contopoulos-Ioan-
nidis and Colberg-Poley, unpublished results). Extracted
DNA or specimens were used directly for PCR as previ-
ously described (Lesperance et al., 1998).
PCR sequencing
The sequencing strategy involved NPCR as described
above, purification of PCR products using QIAquick gel
extraction kit (Qiagen, Chatsworth, CA), and PCR se-
quencing using UL37 sequencing primers (Table 2).
Primers 132, 140, 154, 156, 157, 172, and 187 allowed for
sequencing of the UL37 promoter (nts 52,764–52,770),
UL37x1 ORF (nts 52,218–52,706), and the polyadenylation
signal (nts 51,018–51,023) used for the processing of the
UL37x1/38 unspliced RNA (Tenney and Colberg-Poley,
1991a,b). Sequencing reactions were compared to that of
HCMV strain AD169, sequenced in parallel. Substitutions
in primary strains were sequenced at least three times to
verify their identities independently of PCR amplification
during sequencing.
Deletion mutagenesis
The GeneEditor in vitro site-directed mutagenesis sys-
tem (Promega, Madison, WI) and the QuikChange site-
directed mutagenesis kit (Stratagene, La Jolla, CA) were
used to generate deletion mutants of UL37x1 ORF, start-
ing from UL37x1myc/pcDNA3, a mammalian expression
vector for C-terminally myc-tagged pUL37x1 encoded by
the AD169 strain of HCMV (Goldmacher et al., 1999). The
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239HCMV pUL37x1 CONSERVATION IN PRIMARY STRAINSfidelity of all deletion mutants listed in Fig. 1 was con-
firmed by DNA sequencing.
Cell culture, transfection, and apoptosis assays
HeLa cells were purchased from the ATCC. 293T cells
were a gift from G. Nolan (Stanford University). Cells
were cultured in DMEM supplemented with 10% fetal
bovine serum. Transfections and apoptosis assays were
performed as previously described (Goldmacher et al.,
1999). Briefly, cells were transiently transfected with ex-
pression plasmids (purified with a Qiagen plasmid puri-
fication kit) using SuperFect transfection reagent (Qia-
gen) in accordance with the manufacturer’s protocol.
After 24 h cells were exposed for an additional 24 h to
anti-Fas 7C11 antibody (0.5 mg/ml; Coulter, Hialeah, FL)
1 cycloheximide (10 mg/ml; Sigma, St. Louis, MO). The
cells were then visually observed under phase micro-
scope. Each mutant was tested for its antiapoptotic ac-
tivity in two or more independent experiments.
Protein blots
Western blots were performed as previously described
(Goldmacher et al., 1999). Briefly, cells were lysed in 150
M NaCl, 5 mM EDTA, 50 mM Tris–HCl, pH 8.0, and 1%
riton X-100, in the presence of protease inhibitors, and
entrifuged at 10,000 g at 4°C for 10 min. Protein sam-
les were separated under reduced conditions by SDS–
AGE after being loaded at equal protein amounts per
ell, and analyzed by a standard Western blot protocol
ith 9E10 anti-myc antibody using the ECL detection
ystem (Amersham, Arlington Heights, IL).
mmunofluorescence microscopy
The immunofluorescence experiments were per-
ormed essentially as described in Goldmacher et al.
1999). Full-length pUL37x1myc and deletion mutants
ere detected with 9E10 anti-myc monoclonal antibody,
nd counterstained with anti-human mitochondria anti-
ody (Immunovision, Springdale, AR), mitotracker dye (a
itochondrial marker; Molecular Probes, Eugene, OR), or
ith one of the following endoplasmic reticulum mark-
rs: anti-calnexin (rabbit polyclonal), anti-calreticulin
rabbit polyclonal), or anti-PDI (mouse monoclonal, MAb
D3), all from StressGen (Vancouver, British Columbia,
anada).
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